Skip to main content
. 2018 Jan 11;2018:4174232. doi: 10.1155/2018/4174232

Figure 1.

Figure 1

Hypoxia-induced prostate cancer cell resistance to docetaxel. (a–c) CCK-8 detection of viability of prostate cancer cells in normoxic or hypoxic conditions after docetaxel treatment. (d–f) EdU assay detection of the proliferation rate of prostate cancer cells treated with docetaxel under normoxic or hypoxic conditions. ∗∗P < 0.01 versus docetaxel.